Scientific Sessions 2025  /  Cardiometabolic Interventions for the Vulnerable Plaque and Vulnerable Patient  /  Implications of GLP1 Agonism for Atherosclerosis Disease Progression
Logo

American Heart Association

  27
  0

Final ID:

Implications of GLP1 Agonism for Atherosclerosis Disease Progression

  • Lincoff, Abraham  ( CLEVELAND CLINIC , Cleveland , Ohio , United States )
  • Packer, Milton  ( BAYLOR HEART AND VASCULAR INSTITUTE , Dallas , Texas , United States )
    • Author Disclosures:
    Abraham Lincoff: DO have relevant financial relationships ; Consultant:Novo Nordisk:Active (exists now) ; Researcher:Esperion:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Consultant:TD Cowen:Past (completed) ; Consultant:Besins:Past (completed) ; Consultant:Vwave:Past (completed) ; Consultant:Amgen:Active (exists now) ; Consultant:Alnylam:Past (completed) ; Consultant:Brainstorm Cell:Past (completed) ; Consultant:Eli Lilly:Active (exists now) | Milton Packer: DO have relevant financial relationships ; Consultant:Lilly:Active (exists now) ; Consultant:v-Wave:Past (completed) ; Consultant:Noco Nordisk:Past (completed) ; Consultant:AstraZeneca:Past (completed) ; Consultant:ARMGO:Active (exists now) ; Consultant:Novartis:Past (completed) ; Consultant:Regeneron:Active (exists now) ; Consultant:Attralus:Active (exists now) ; Consultant:Biopeutics:Past (completed) ; Consultant:Salamandra:Past (completed) ; Consultant:Pharmacocosmos:Past (completed) ; Consultant:Altimmune:Active (exists now) ; Consultant:Amgen:Past (completed) ; Consultant:Abbvie:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiometabolic Interventions for the Vulnerable Plaque and Vulnerable Patient

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Imaging Atherosclerosis to Study Disease, Understand Patients and Guide Therapy

Narula Jagat, Maehara Akiko

Opportunities to Implement Cardiometabolic Health Promotion in the Cardiac Cath Lab

Michos Erin, Shapiro Michael

More abstracts from these authors:
Tirzepatide for Patients With Heart Failure With Preserved Ejection Fraction and Obesity: the SUMMIT Trial

Packer Milton

Blinded Withdrawal of Long-term Randomized Treatment with Empagliflozin or Placebo in Patients With Heart Failure

Packer Milton

You have to be authorized to contact abstract author. Please, Login
Not Available